Ascending Single-dose Study to Evaluate TVB-2640 in Chinese Healthy Subjects

NCT04352361 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: TVB-2640
DRUG: Placebo

Sponsor

Ascletis Pharmaceuticals Co., Ltd.